Prospective observational study on image quality and diagnostic ability evaluation by glucagon administration during prostate MRI scan

Prospective observational study on image quality and diagnostic ability evaluation by glucagon administration during prostate MRI scan - Glucagon administration test at prostate MRI scan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038516

Enrollment

Registered

2020-04-01

Start date

2019-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Glucagon administration

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: (1) Situation where prostate cancer or prostate cancer is suspected (2) Regardless of stage or stage when prostate cancer is diagnosed (3) Up to 80 years old (4) Male

Exclusion criteria

Exclusion criteria: Excluded if consent to this study is not obtained.

Design outcomes

Primary

Measure	Time frame
It is an objective index (quantitative) for image quality evaluation, and performs SNR (signal-to-noise ratio) evaluation.	—

Countries

Japan

Contacts

Public ContactNaoko Mori

Tohoku University Diagnostic Radiology

naokomori7127@gmail.com0227177312

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026